18f-ftc-146 (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
206 | Fragile X syndrome | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04314856 (ClinicalTrials.gov) | June 2020 | 11/3/2020 | Novel Clinical Target in Fragile X Syndrome | Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome | Fragile X Syndrome (FXS) | Drug: 18F-FTC-146 | Stanford University | NULL | Not yet recruiting | 18 Years | 65 Years | All | 20 | Phase 1 | United States |